Breakthrough ALS study launches as drug aims to slow disease progression

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials.

ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association states. This slowly strips away a person’s ability to walk, talk, eat, dress, write, speak, swallow and, eventually, breathe.

The "PREVAiLS" study, which will review the investigational drug pridopidine as a potential ALS treatment, has already enrolled its first participant, according to...